Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Oncogene|March 17, 2018
Collagen abundance controls melanoma phenotypes through lineage-specific microenvironment sensingZsofia Miskolczi, Michael P Smith, Emily J Rowling, et al.
The Journal of Clinical Endocrinology and Metabolism|October 14, 2011
GDC-0941 inhibits metastatic characteristics of thyroid carcinomas by targeting both the phosphoinositide-3 kinase (PI3K) and hypoxia-inducible factor-1α (HIF-1α) pathwaysNatalie Burrows, Muhammad Babur, Julia Resch, et al.
Pigment Cell & Melanoma Research|October 3, 2018
A PAX3/BRN2 rheostat controls the dynamics of BRAF mediated MITF regulation in MITFhigh /AXLlow melanomaMichael P Smith, Sareena Rana, Jennifer Ferguson, et al.
Bioorganic & Medicinal Chemistry|December 3, 2013
Detection of apoptosis by PET/CT with the diethyl ester of [¹⁸F]ML-10 and fluorescence imaging with a dansyl analogueManikandan Kadirvel, Michael Fairclough, Christopher Cawthorne, et al.
Pigment Cell & Melanoma Research|March 8, 2020
Cooperative behaviour and phenotype plasticity evolve during melanoma progressionEmily J Rowling, Zsofia Miskolczi, Raghavendar Nagaraju, et al.
Oncotarget|August 17, 2016
Phosphatidylinositide 3-kinase (PI3K) and PI3K-related kinase (PIKK) activity contributes to radioresistance in thyroid carcinomasNatalie Burrows, Joseph Williams, Brian A Telfer, et al.
Cancer Cell|March 16, 2016
Inhibiting Drivers of Non-mutational Drug Tolerance Is a Salvage Strategy for Targeted Melanoma TherapyMichael P Smith, Holly Brunton, Emily J Rowling, et al.
The Journal of Experimental Medicine|April 29, 2017
An adaptive signaling network in melanoma inflammatory niches confers tolerance to MAPK signaling inhibitionHelen L Young, Emily J Rowling, Mattia Bugatti, et al.
EMBO Molecular Medicine|June 14, 2017
Targeting endothelin receptor signalling overcomes heterogeneity driven therapy failureMichael P Smith, Emily J Rowling, Zsofia Miskolczi, et al.
Pageof 1